Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
Lloyd KA, Parsons BN, Burkitt MD, Moore AR, Papoutsopoulou S, Boyce M, Duckworth CA, Exarchou K, Howes N, Rainbow L, Fang Y, Oxvig C, Dodd S, Varro A, Hall N, Pritchard DM.
Lloyd KA, et al. Among authors: burkitt md.
Cell Mol Gastroenterol Hepatol. 2020;10(1):113-132. doi: 10.1016/j.jcmgh.2020.01.010. Epub 2020 Jan 28.
Cell Mol Gastroenterol Hepatol. 2020.
PMID: 32004755
Free PMC article.
Clinical Trial.